Selegiline induces neuronal phenotype and neurotrophins expression in embryonic stem cells

Rejuvenation Research

Volumn 9, Issue 4, 2006, Pages 475-484

  Esmaeili, Fariba ^a   Tiraihi, Taki ^a   Movahedin, Mansoureh ^a   Mowla, Seyed Javad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BUCLADESINE; COMPLEMENTARY DNA; DIMETHYL SULFOXIDE; DOXORUBICIN; GENOMIC DNA; INTERLEUKIN 2; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPIN; RETINOIC ACID; RNA; SELEGILINE;

AGING; ANIMAL CELL; ARTICLE; CELL CULTURE EQUIPMENT; CELL DIFFERENTIATION; CELL VIABILITY; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EMBRYONIC STEM CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FEASIBILITY STUDIES; MICE; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; SELEGILINE;

EID: 33846207955     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2006.9.475     Document Type: Article

References (60)

1. Knoll J. The facilitation of dopaminergic activity in the aged brain by (-)deprenyl. A proposal for a strategy to improve the quality of life in senescence. Mech Ageing Dev 1985;30:109-122.
2. Knoll J. Deprenyl (selegiline): the history of its development and pharmacological action. Acta Neurol Scand 1983;95:57-80.
3. Kitani K, Kanal S, Sato Y, Ohta M, Ivy GO, Carrillo MC. Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats. Further evidence. Life Sci 1993;52:281-288.
4. Brandeis R, Sapir M, Kapon Y, Borelli G, Cadel S, Valsecchi B. Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats. Pharmacol Biochem Behav 1991;39:297-304.
5. de Lima MN, Laranja DC, Caldana F, Bromberg E, Roesler R, Schroder N. Reversal of age-related deficits in object recognition memory in rats with 1-deprenyl. Exp Gerontol 2005;40:506-511.
6. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005;19:1129-1155.
7. Min JY, Chen Y, Malek S, Meissner A, Xiang M, Ke Q, Feng X, Nakayama M, Kaplan E, Morgan JP. Stem cell therapy in the aging hearts of Fisher 344 rats: synergistic effects on myogenesis and angiogenesis. J Thorac Cardiovasc Surg 2005;130:547-553.
8. He Q, Li J, Bettiol E, Jaconi ME. Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people. J Gerontol Biol Sci Med Sci 2003;58:279-287.
9. Wobus AM, Grosse R, Schoneich J. Specific effects of nerve growth factor on the differentiation pattern of mouse embryonic stem cells in vitro. Biomed Biochim Acta 1988;47:965-973.
10. Andrews PW. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 1984;103:285-293.
11. Sasai Y. Generation of dopaminergic neurons from embryonic stem cells. J Neurol 2002;249:II41-44.
12. Rolletschek A, Chang H, Guan K, Czyz J, Meyer M, Wobus AM. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech Dev 2001;105:93-104.
13. Dinsmore J, Ratliff J, Deacon T, Pakzaban P, Jacoby D, Galpern W, Isacson O. Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transpl 1996;5:131-143.
14. Schmidt MM, Guan K, Wobus AM. Lithium influences differentiation and tissue-specific gene expression of mouse embryonic stem (ES) cells in vitro. Int J Dev Biol 2001;45:421-429.
15. Miklya I, Knoll B, Knoll J. A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study. Life Sci 2003;72:2641-2648.
16. Maruyama W, Takahashi T, Youdim M, Naoi M. The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. J Neural Transm 2002;109:467-481.
17. Hobbenaghi R, Tiraihi T. Neuroprotective effect of deprenyl in sensory neurons of axotomized dorsal root ganglion. Clin Neuropharmacol 2003;26:263-269.
18. Iwasaki Y, Ikeda K, Shiojima T, Kobayashi T, Tagaya N, Kinoshitam M. Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons. J Neurol Sci 1994;125:11-13.
19. Koutsilieri E, O'Callaghan JF, Chen TS, Riederer P, Rausch WD. Selegiline enhances survival and neurite outgrowth of MPP(+)-treated dopaminergic neurons. Eur J Pharmacol 1994;269:R3-4.
20. Kontkanen O, Castren E. Trophic effects of selegiline on cultured dopaminergic neurons. Brain Res 1999;829:190-192.
21. Mizuta I, Ohta M, Ohta K, Nishimura M, Mizuta E, Hayashi K, Kuno S. Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes. Bioch Biophys Res Commun 2000;279:751-755.
22. Lee SH, Han JH, Choi JH, Huh EY, Kwon YK, Kaang BK. The effect of brain-derived neurotrophic factor on neuritogenesis and synaptic plasticity in Aplasia neurons and the hippocampal cell line HiB5. Mol Cells 2003;15:233-239.
23. Freshney RI. Culture of animal cells: a manual of basic technique. New York: Wiley-Liss, 1994.
24. Ratkowsky DA. Nonlinear regression modeling: a unified practical approach. New York: Marcel Decker, 1983.
25. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the Mouse Embryo: a Laboratory Manual, 2nd ed. New York: Cold Springer Harbor Laboratory Press, 1994.
26. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995;168:342-357.
27. Seki M, Tanaka T, Sakai Y, Fukuchi T, Abe H, Nawa H, Takei N. Muller cells as a source of brain-derived neurotrophic factor in the retina: noradrenaline upregulates brain-derived neurotrophic factor levels in cultured rat Muller cells. Neurochem Res 2005;30:1163-1170.
28. Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press, 2001.
29. Limke TL, Rao MS. Neural stem cell therapy in the aging brain: pitfalls and possibilities. J Hematother Stem Cell Res 2003;12:615-623.
30. Bernal GM, Peterson DA. Neural stem cells as therapeutic agents for age-related brain repair. Aging Cell 2004;3:345-351.
31. Brazel CY, Rao MS. Aging and neuronal replacement. Ageing Res Rev 2004;3:465-483.
32. Knoll J. Extension of life span of rats by long-term (-)deprenyl treatment. Mt Sinai J Med 1988;55:67-74.
33. Archer JR, Harrison DE. L-Deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by aged males. J Gerontol A Biol Sci Med Sci 1996;51:B448-453.
34. Ruehl WW, Entriken TL, Muggenburg BA, Bruyette DS, Griffith WC, Hahn FF. Treatment with L-deprenyl prolongs life in elderly dogs. Life Sci 1997;61:1037-1044.
35. Carrillo MC, Kanai S, Sato Y, Nokubo M, Ivy GO, Kitani K. The optimal dosage of (-)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats. Life Sci 1993;52:1925-1934.
36. Kitani K, Minami C, Isobe K, Maehara K, Kanai S, Ivy GO, Carrillo MC. Why (-)deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects. Mech Ageing Dev 2002;123:1087-1100.
37. Ekblom J, Jossan SS, Ebendal T, Soderstrom S, Oreland L, Aquilonius SM. mRNA expression of neurotrophins and members of the trk family in the rat brain after treatment with L-deprenyl. Acta Neurol Scand 1994;89:147-148.
38. De la Cruz CP, Revilla E, Rodriguez-Gomez JA, Vizuete ML, Cano J, Machado A. (-)-Deprenyl treatment restores serum insulin-like growth factor-I (IGF-I) levels in aged rats to young rat level. Eur J Pharmacol 1997;327:215-220.
39. Rylett RJ, Williams LR. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci 1994;17:486-490.
40. Kelley MW, Turner T, Reh TA. Retinoic acid promotes differentiation of photoreceptors in vitro. Development 1994;120:2091-2102.
41. Wohl CC, Weiss S. Retinoic acid enhances neuronal proliferation and astroglial differentiation in cultures of CNS stem cell-derived precursors. J Neurobiol 1998;37:281-290.
42. Han G, Chang B, Connor MJ, Sidell N. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells. Dif-ferentiation 1995;59:61-69.
43. Ensoli F, Fiorelli V, Vannelli B, Barni T, De Cristofaro M, Ensoli B, Thiele CJ. Basic fibroblast growth factor supports human olfactory neurogenesis by autocrine/paracrine mechanisms. Neuroscience 1998;86:881-893.
44. Tatton WG, Wadia JS, Ju WY, Chalmers-Redman RM, Tatton NA. (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase. J Neural Transm 1996;48:45-59.
45. Semkova I, WoIz P, Schilling M, Krieglstein J. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur J Pharmacol 1996;315:19-30.
46. Shimazu, S, Tanigawa A, Sato N, Yoneda F, Hayashi K, Knoll J. Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane ((-)BPAP) enhance the neurotrophic factor synthesis on cultured mouse astrocytes. Life Sci 2003;72:2785-2792.
47. Chiba S, Iwasaki Y, Sekino H, Suzuki N. Transplantation of motoneuron-enriched neural cells derived from mouse embryonic stem cells improves motor function of hemiplegic mice. Cell Transpl 2003;12:457-468.
48. Schuldiner M, Eiges R, Eden A, Yanuka O, Itskovitz-Eldor J, Goldstein R, Benvenisty N. Induced neuronal differentiation of human embryonic stem cells. Brain Res 2001;913:201-205.
49. Sun Y, Maxwell GD. Ciliary neurotrophic factor (CNTF) has a dose-dependent biphasic effect on the number of adrenergic cells which develop in avian trunk neural crest cultures. Neurosci Lett 1994;165:1-4.
50. Benninghoff J, Schmitt A, Mossner R, Lesch KP. When cells become depressed: focus on neural stem cells in novel treatment strategies against depression. J Neurol Transm 2002;109:947-962.
51. Engele J. Spatial and temporal growth factor influ-ences on developing midbrain dopaminergic neurons. J Neurosci Res 1998;53:405-414.
52. Boukhaddaoui H, Sieso V, Scamps F, Valmier J. An activity-dependent neurotrophin-3 autocrine loop regulates the phenotype of developing hippocampal pyramidal neurons before target contact. J Neurosci 2001;21:8789-8797.
53. Rodriguez-Gomez JA, Venero JL, Vizuete ML, Cano J, Machado A. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system. Brain Res Mol Brain Res 1997;46:31-38.
54. Park S, Lee KS, Lee YJ, Shin HA, Cho HY, Wang KC, Kim YS, Lee HT, Chung KS, Kim EY, Lim J. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci Lett 2004;359:99-103.
55. Weiss L, Reich S, Slavin S. Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapy. Cancer Invest 1992;10:19-26.
56. Cesano A, Visonneau S, Rovera G, Santoli D. Synergistic effects of Adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo. Anticancer Res 1997;17:1887-1892.
57. Ishii S, Hiroishi K, Eguchi J, Hiraide A, Imawari M. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established rumors in a murine colorectal cancer model. Gene Ther 2006;13:78-87.
58. Yang Y, Min JY, Rana JS, Ke Q, Cai J, Chen Y, Morgan JP, Xiao YF. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 2002;93:1140-1151.
59. Barbero A, Benelli R, Minghelli S, Tosetti F, Dorcaratto A, Ponzetto C, Wernig A, Cullen MJ, Albini A, Noonan DM. Growth factor supplemented matrigel improves ectopic skeletal muscle formation-a cell therapy approach. J Cell Physiol 2001;186:183-192.
60. Jonakait GM, Wen Y, Wan Y, Ni L. Macrophage cell-conditioned medium promotes cholinergic differentiation of undifferentiated progenitors and synergizes with nerve growth factor action in the developing basal forebrain. Exp Neurol 2000;161:285-296.